Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series Ltd: World’s leading Event Organizer
Omics International publishes 304 Open Access Articles in 13 International Journals it has 32 Upcoming Conferences and 15 Previous Conferences with 581 Conference Proceedings and 92 National symposiums.
Neuropsychopharmacology, a disciplinary science related to psychopharmacology and neuroscience, which is the study of the neural mechanisms that drugs act upon to effect activity. Neuropsychopharmacology explains psychopharmacology in the areas brain functioning. Developments in Neuro psycho pharmacology directly show impact on the research of anxiety disorders, psychotic diseases, and neurodegenerative disorders.
OMICS International through its Open access initiatives is committed to make genuine and reliable contributions to the scientific community by publishing research work and conference paper related to such disorders. It is known that OMICS Group hosts over 700 edge peer reviewed Open Access Journals and organizes over more than 1000 Global Events annually. Its publishing group journals have over 5 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 75000+ eminent personalities that ensure a quality and quick review process checker.
Neuropsychopharmacology relates to clinical and basic science collaborations that advance our functioning of the brain and behaviour, especially as related to the physiological and psychological properties of agents acting within the CNS and the identification of the new molecular targets for the development of the second generation drugs. Developments in neuropsychopharmacology directly impact the studies of anxiety disorders, affective disorders, psychotic disorders, degenerative disorders, eating behaviour, and sleep behaviour. By the 20th century, the essential work of all the central features of neurotransmission had been gained.
Research of neuropsychopharmacology comes from basis of activities in neuroscience and clinical studies. This has motivated organizations such as the American College of Neuropsychopharmacology, the European College of Neuropsychopharmacology, and the Collegium International Neuro-psychopharmacologicum to be established for focus. The ECNP published European Neuropsychopharmacology, part of the Reed Elsevier Group, the ACNP publishes the journal Neuropsychopharmacology, and the CINP publishes the journal International Journal of Neuropsychopharmacology with Cambridge University Press. In 2002, the most recent comprehensive collected work of the ACNP, Neuropsychopharmacology is the Fifth Generation of Progress was compiled. It is one measure of the current state of knowledge, and might be said to represent a landmark in the century-long goal to establish the basic neuron-biological principles which govern the actions of the brain.
This page will be updated regularly.
This page was last updated on 11th Sep, 2015
1-702-508-5200 Ext:8031, 8041
1-702-508-5200 Ext:8045, 8047
Immunology & Microbiology Conferences
Nursing and Healthcare Conferences
Clinical and Biochemistry Conferences
1-702-508-5200 Ext:8031, 8037
Material Science Conferences
Genetics & Mol Biology Conferences
Media Partners | Advertising